{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:12:28Z","timestamp":1790957548917,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.tox.2014.02.009","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T19:30:25Z","timestamp":1393961425000},"page":"38-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"319","author":[{"given":"Jes\u00fas","family":"P\u00e9rez-H","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Carrillo-S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Ruiz-Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruy","family":"P\u00e9rez-Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-0461","authenticated-orcid":false,"given":"Anah\u00ed","family":"Chavarr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2014.02.009_bib0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neulet.2010.06.038","article-title":"Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress","volume":"480","author":"Baluchnejadmojarad","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tox.2014.02.009_bib0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1471-4159.2001.00066.x","article-title":"Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells","volume":"76","author":"De Girolamo","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2014.02.009_bib0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tox.2014.02.009_bib0025","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease","volume":"81","author":"Gao","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2014.02.009_bib0030","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/BF00966824","article-title":"Ventricular injection of nerve growth factor increases dopamine content in the striata of MPTP-treated mice","volume":"17","author":"Garcia","year":"1992","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tox.2014.02.009_bib0035","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1080\/10715760802506356","article-title":"Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine","volume":"10","author":"Garcia","year":"2008","journal-title":"Free Radic. Biol. Res."},{"key":"10.1016\/j.tox.2014.02.009_bib0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.phymed.2010.04.004","article-title":"S-allylcysteine reduces the MPTP-induced striatal cell damage via inhibition of pro-inflammatory cytokine tumor necrosis factor-\u03b1 and inducible nitric oxide synthase expressions in mice","volume":"18","author":"Garcia","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.tox.2014.02.009_bib0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986707779941159","article-title":"Silybin and silymarin \u2013 new and emerging applications in medicine","volume":"14","author":"Gaz\u00e1k","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tox.2014.02.009_bib0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(96)13148-7","article-title":"Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells","volume":"218","author":"Green","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tox.2014.02.009_bib0050","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-2002-35663","article-title":"Physiological responses to a natural antioxidant flavonoid mixture, silymarin, in BALB\/c mice: II. Alterations in thymic differentiation correlate with changes in c-myc gene expression","volume":"68","author":"Johnson","year":"2002","journal-title":"Planta Med."},{"key":"10.1016\/j.tox.2014.02.009_bib0060","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3748\/wjg.v17.i18.2288","article-title":"Silybin and the liver: from basic research to clinical practice","volume":"17","author":"Loguercio","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tox.2014.02.009_bib0065","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1476-5381.2009.00295.x","article-title":"Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice","volume":"157","author":"Lu","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2014.02.009_bib0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbr.2009.10.024","article-title":"Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment","volume":"207","author":"Lu","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tox.2014.02.009_bib0075","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1177\/0960327112436405","article-title":"Long-term administration of Silymarin augments proinflammatory mediators in the hippocampus of rats: evidence for antioxidant and pro-oxidant effects","volume":"31","author":"Malekinejad","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2014.02.009_bib0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.phymed.2006.02.005","article-title":"Protective effect of silymarin on oxidative stress in rat brain","volume":"14","author":"Nencini","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1016\/j.tox.2014.02.009_bib0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2011.07.035","article-title":"Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: a behavioral, biochemical and immunohistological study in Wistar rats","volume":"309","author":"Raza","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tox.2014.02.009_bib0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000070277","article-title":"Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice","volume":"77","author":"Ramirez","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.tox.2014.02.009_bib0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-079X.2010.00819.x","article-title":"Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse","volume":"50","author":"Singhal","year":"2011","journal-title":"J. Pineal. Res."},{"key":"10.1016\/j.tox.2014.02.009_bib0105","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-013-1780-x","article-title":"Silymarin- and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism","author":"Singhal","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tox.2014.02.009_bib0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.tox.2014.02.009_bib0115","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/NEN.0b013e3181b35e41","article-title":"Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys","volume":"68","author":"V\u00e1zquez-Claverie","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tox.2014.02.009_bib0120","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1046\/j.1460-9568.2002.02290.x","article-title":"Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation","volume":"16","author":"Wang","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tox.2014.02.009_bib0125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2202-13-142","article-title":"Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson's disease","volume":"14","author":"Wang","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.tox.2014.02.009_bib0130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1289\/ehp.5494","article-title":"Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity","volume":"111","author":"Welshons","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2014.02.009_bib0135","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jpba.2007.06.026","article-title":"Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application","volume":"45","author":"Wu","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.tox.2014.02.009_bib0140","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1124\/dmd.113.052423","article-title":"An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study","volume":"41","author":"Zhu","year":"2013","journal-title":"Drug. Metab. Dispos."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X14000341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X14000341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:26:49Z","timestamp":1759534009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X14000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":26,"alternative-id":["S0300483X14000341"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2014.02.009","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2014.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}